| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/2004 | CN1511949A Method for producing parathyroid hormone derivative by recombination and expression carrier used thereof |
| 07/14/2004 | CN1511948A Method for constructing genome library |
| 07/14/2004 | CN1511947A Gene expression preventing chronic transplanting rejection of recombined gland relative virus mediated haem oxidase-1 (HO-1) |
| 07/14/2004 | CN1511849A Novel alpha interferon mutant and its preparing process |
| 07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
| 07/14/2004 | CN1511845A Candida albicans molecular companion gere and its use |
| 07/14/2004 | CN1511844A Pig pleuropneumonia actino bacillus gene engineering toxoid ApxI and dead bacterium mixed vaccine |
| 07/14/2004 | CN1511842A Rockfish insulin-like growth factor I gene and carrier containing said gene and recombined strain and its use |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1157480C Butyrobetaine/crotonbetaine-L-carnitine metabolic gene and its use in producing L-carnition by microbial method |
| 07/14/2004 | CN1157479C Virus expression veclor of tomato flower-leaf virus low virulent strain K |
| 07/14/2004 | CN1157478C Improved barster gene |
| 07/14/2004 | CN1157410C Human g-protein coupled receptor (HETGQ 23) |
| 07/14/2004 | CN1157409C Genetically engineered fish growth hormone and its use in aquatic product culture |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/14/2004 | CN1157405C Preparation method of cholera toxin B sub unit |
| 07/14/2004 | CN1157344C Biochemical process for treating waste waster with nano material carbon black |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762348 Genetic control of plant growth and development |
| 07/13/2004 | US6762347 NOR gene compositions and methods for use thereof |
| 07/13/2004 | US6762346 Transgenic plants and plant cells, in which an amylopectin with an altered degree of branching is synthesized |
| 07/13/2004 | US6762345 For oils rich in keto fatty acids which are useful for industrial applications such as drying agents and monomer precursors |
| 07/13/2004 | US6762344 For herbicide resistance, male sterility |
| 07/13/2004 | US6762343 Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hypothermia, and colitis and provide a mouse model for cancer |
| 07/13/2004 | US6762342 Expression vector for use in generating animal model to evaluate genetic disorders sensitivity to pain and tension |
| 07/13/2004 | US6762341 Treating asthma in animals; antiinflammatory/bronchodilator agents; drug screening |
| 07/13/2004 | US6762297 Comprise nucleotide sequences coding cyprinus growth hormone gene for generating transgenic fish with increased growth rates; animal husbandry |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762292 Optimally labeled oligonucleotides |
| 07/13/2004 | US6762291 Used to modify insects and worms, or cultured cells, resulting in p53 expression or mis-expression; modified organisms or cells are used in screening assays to identify potential pesticidal agents or therapeutics that interact with p53 |
| 07/13/2004 | US6762290 Includes rna ligands that inhibit the interaction of a vegf receptor with vegf |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762285 Bs2 resistance protein |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6762048 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
| 07/13/2004 | US6762040 Generation of expression in microorganismal cell; obtain cell, incubate with vector, transform, amplfify vector, recover vector |
| 07/13/2004 | US6762037 Process for producing coenzyme Q10 |
| 07/13/2004 | US6762031 Viral expression library for use as tools in gene therapy |
| 07/13/2004 | US6762027 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6762021 Method for diagnosis of crohn's disease |
| 07/13/2004 | US6762019 Use in activated slides for making microarrays of nucleic acids; monomers with pendant epoxy groups to immobilize biological targets, diluent monomers or polymers, and monomers having a photoreactive group to surface treat the substrate |
| 07/13/2004 | US6761916 Method for producing breads with a recombinant yeast which expresses a photoprotein |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761891 Medicament for treating a manifested lyme disease |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | US6761884 The negative selective marker enables one to kill cells which contain the gene encoding the negative selective marker, when a particular agent is administered to such cells, gene thearpy |
| 07/13/2004 | US6761876 Methods for introducing helterologous cells into fish |
| 07/13/2004 | CA2414487A1 Methods and genetic sequences for producing male sterile plants, and plants genetically modified to alter anther development |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/13/2004 | CA2123908C Novel dna clones and uses thereof |
| 07/13/2004 | CA2052413C Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods |
| 07/08/2004 | WO2004057028A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 07/08/2004 | WO2004057017A2 Detection of small nucleic acids |
| 07/08/2004 | WO2004057016A2 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN |
| 07/08/2004 | WO2004057006A1 Genetic therapy and genetic modification using neocentromeric minichromosomes |
| 07/08/2004 | WO2004057005A1 Vectors lacking an origin of replication functioning in mammalian cells and expressing growth factors |
| 07/08/2004 | WO2004057004A2 Plant genes and their use in controlling abcission in plants |
| 07/08/2004 | WO2004057003A2 Method for producing aminoacids |
| 07/08/2004 | WO2004057002A2 Production of heterologous glycosylated proteins in bryophyte cells |
| 07/08/2004 | WO2004057001A2 Method for the production of polyunsaturated fatty acids |
| 07/08/2004 | WO2004057000A2 Methods and compositions for modulating tuber formation in tuber-producing plants |
| 07/08/2004 | WO2004056999A1 Plant cells and plants which synthesize a starch with an increased final viscosity |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056997A1 A human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it |
| 07/08/2004 | WO2004056995A1 Process for producing an in vitro peptide expression library |
| 07/08/2004 | WO2004056994A2 Quasirandom structure and function guided synthesis methods |
| 07/08/2004 | WO2004056993A1 Plant with reduced protein content in seed, method of constructing the same and method of using the same |
| 07/08/2004 | WO2004056992A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056990A1 Novel nitrile hydratase |
| 07/08/2004 | WO2004056989A2 Human variants of kallikrein-2 and kallikrein-3 and uses thereof |
| 07/08/2004 | WO2004056987A1 Modulation of the thioredoxin pathway |
| 07/08/2004 | WO2004056986A2 Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors |
| 07/08/2004 | WO2004056984A2 Enzymatic method for the isolation of dna from plant tissue |
| 07/08/2004 | WO2004056983A2 Metalloprotease proteins |
| 07/08/2004 | WO2004056979A2 Recombinant virus production for the manufacturing of vaccines |
| 07/08/2004 | WO2004056977A1 Production of alvac on avian embryonic stem cells |
| 07/08/2004 | WO2004056974A2 Mutations affecting carotenoid production |
| 07/08/2004 | WO2004056973A2 Method for chromosomal engineering |
| 07/08/2004 | WO2004056972A2 Parallel chromosomal stacking of traits in bacteria |
| 07/08/2004 | WO2004056971A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/08/2004 | WO2004056969A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004056968A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004056967A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004056966A2 Methods of inhibiting gene expression by rna interference |
| 07/08/2004 | WO2004056965A2 Nucleic acids encoding antifungal drug targets and methods of use |
| 07/08/2004 | WO2004056964A2 Vectors for inducible rna interference |
| 07/08/2004 | WO2004056875A1 Antibodies against pd-1 and uses therefor |
| 07/08/2004 | WO2004056871A2 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | WO2004056859A1 Il-8-like proteins |
| 07/08/2004 | WO2004056858A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 07/08/2004 | WO2004056857A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 07/08/2004 | WO2004056856A1 Inactive transcription factor tif-ia and uses thereof |
| 07/08/2004 | WO2004056851A1 Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response |
| 07/08/2004 | WO2004056850A2 Mutant proteins showing increased secretion |